Healthcare -
Biotechnology - NASDAQ - US
$ 279.01
0.667 %
$ 36 B
Market Cap
-106.09
P/E
ALNY - DEPRECIATION & AMORTIZATION
Depreciation & Amortization ALNY - Alnylam Pharmaceuticals, Inc.
97 M
LAST VALUE
4.01%
2 YEAR CAGR
72.06%
5 YEAR CAGR
25.23%
10 YEAR CAGR